Inventor profile of:

Richard E. Olson

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

27

Last publication date:

2025-10-23

Top Assignees for applications by Richard E. Olson

The entities that hold a legal rights for patent applications filed by inventor Olson Richard E.:

Recent patent applications by Olson Richard E.

Richard E. Olson from Cambridge, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2025-10-23
US20250327072A1
Chemistry; metallurgy

ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF

#2 | 2025-06-12
US20250188463A1
Chemistry; metallurgy

ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF

#3 | 2025-05-01
US20250136988A1
Chemistry; metallurgy

ANTISENSE OLIGONUCLEOTIDES TARGETING ALPHA-SYNUCLEIN AND USES THEREOF

#4 | 2024-12-05
US20240400563A1
Chemistry; metallurgy

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

#5 | 2024-01-25
US20240026360A1
Chemistry; metallurgy

OLIGONUCLEOTIDES FOR MODULATING TAU EXPRESSION

#6 | 2023-08-03
US20230242569A1
Chemistry; metallurgy

Phosphorus (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophosphorus (V) compounds

#7 | 2023-06-22
US20230193260A1
Chemistry; metallurgy

Antisense oligonucleotides targeting alpha-synuclein and uses thereof

#8 | 2023-05-18
US20230151007A1
Chemistry; metallurgy

SUBSTITUTED PYRIDOPYRIMIDINONYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

#9 | 2023-04-20
US20230118629A1
Chemistry; metallurgy

SUBSTITUTED PIPERAZINE DERIVATIVES USEFUL AS T CELL ACTIVATORS

#10 | 2023-03-30
US20230094758A1
Chemistry; metallurgy

SUBSTITUTED QUINAZOLINYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

#11 | 2023-03-23
US20230089255A1
Human necessities

COMBINATIONS OF DGK INHIBITORS AND CHECKPOINT ANTAGONISTS

#12 | 2023-03-23
US20230086933A1
Chemistry; metallurgy

SUBSTITUTED HETEROARYL COMPOUNDS USEFUL AS T CELL ACTIVATORS

#13 | 2023-03-02
US20230061608A1
Chemistry; metallurgy

SUBSTITUTED QUINOLINONYL PIPERAZINE COMPOUNDS USEFUL AS T CELL ACTIVATORS

#14 | 2022-10-13
US20220324859A1
Chemistry; metallurgy

Substituted naphthyridinone compounds useful as T cell activators

#15 | 2022-07-07
US20220213484A1
Chemistry; metallurgy

ANGPTL2 ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF

#16 | 2022-04-21
US20220119811A1
Chemistry; metallurgy

ALPHA-SYNUCLEIN ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF

#17 | 2021-12-09
US20210378652A1
Human necessities

CAMK2D ANTISENSE OLIGONUCLEOTIDES AND USES THEREOF

#18 | 2021-09-09
US20210277004A1
Chemistry; metallurgy

Naphthyridinone compounds useful as T cell activators

#19 | 2021-06-24
US20210188845A1
Chemistry; metallurgy

Substituted bicyclic compounds useful as T cell activators

#20 | 2021-04-29
US20210123054A1
Chemistry; metallurgy

Oligonucleotides for modulating Tau expression

#21 | 2021-03-04
US20210061802A1
Chemistry; metallurgy

Substituted pyridopyrimidinonyl compounds useful as T cell activators

#22 | 2020-11-19
US20200362347A1
Chemistry; metallurgy

Antisense oligonucleotides targeting alpha-synuclein and uses thereof

#23 | 2020-11-12
US20200354720A1
Chemistry; metallurgy

Antisense oligonucleotides targeting alpha-synuclein and uses thereof

#24 | 2020-04-09
US20200109140A1
Chemistry; metallurgy

Substituted naphthyridinone compounds useful as T cell activators

#25 | 2019-12-19
US20190383797A1
Physics

Methods of selecting therapeutic molecules

#26 | 2019-10-24
US20190322694A1
Chemistry; metallurgy

Phosphorous (V)-based reagents, processes for the preparation thereof, and their use in making stereo-defined organophoshorous (V) compounds

#27 | 2019-09-12
US20190275148A1
Human necessities

CAMK2D antisense oligonucleotides and uses thereof

InventorID:

2695514 ⎘